Biological Research at the Department of Energy: Leveraging DOE's Unique Capabilities to Respond to the COVID-19 Pandemic, Hearing Before the Subcommittee on Energy of the Committee on Science, Space, and Technology, House of Representatives, One Hundred Sixteenth Congress, Second Session, September 11, 2020 [open pdf - 89MB]
This is the September 11, 2020 hearing on "Biological Research at the Department of Energy: Leveraging DOE's Unique Capabilities to Respond to the COVID-19 Pandemic," held before the U.S. House Committee on Science, Space, and Technology. From the opening statement of Lizzie Fletcher Webex: "This hearing will examine the historic reasons for why the Department possesses advanced bioscience capabilities to address the Nation's great challenges and to stimulate innovation, how this expertise and DOE's [Department of Energy's] biological research tools are being leveraged to respond to the COVID-19 [coronavirus disease 2019] pandemic, and what future directions for the Department's biological system research can provide solutions for our Nation's most pressing issues." Statements, letters, and materials submitted for the record include those of the following: Mary Maxon, Debra Mohnen, Glenn C. Randall, and Kelly C. Wrighton.
Serial No. 116-80
Government Publishing Office: http://www.gpo.gov/